Gregory Tawa
About Gregory Tawa
Gregory Tawa serves as the TRND Program Modeling and Informatics Lead at the National Institutes of Health's NCATS division, where he has worked since 2014. He has extensive experience in algorithm development and programming, with a background in chemical physics and various roles in research and computational chemistry.
Work at National Institutes of Health
Gregory Tawa serves as the TRND Program Modeling and Informatics Lead at the National Institutes of Health (NIH) within the NCATS division. He has held this position since 2014, contributing to therapeutic discovery projects for the TRND and BrIDGEs programs. His role involves algorithm development and programming, utilizing his expertise in various programming languages.
Education and Expertise
Gregory Tawa earned a PhD in Chemical Physics from New York University, where he studied from 1986 to 1990. He also holds a Bachelor of Science degree in Chemistry from the University of Massachusetts Amherst, completed between 1979 and 1983. His expertise encompasses molecular theory, including classical, quantum, and statistical mechanics.
Professional Background
Gregory Tawa has a diverse professional background in research and development. He worked as a Principal Research Scientist I at Wyeth Research (now Pfizer) from 2002 to 2009. Prior to that, he was a Technical Staff Member at Los Alamos National Laboratory from 1993 to 1995 and served as a Postdoctoral researcher at the University of Minnesota from 1990 to 1993. He also held the position of Director of the Computational Chemistry Group at Tibotec for one year in 2000.
Research Contributions
Gregory Tawa has made significant contributions to scientific literature. He is the lead author of a paper on chemically induced liver injuries published in PLOS ONE in 2014. Additionally, he contributed to a study identifying compounds that block Ebola virus entry, which was published in Emerging Microbes & Infections in the same year.
Previous Positions and Roles
Before his current role at NIH, Gregory Tawa was the Head of the Computational Drug Design Group at The Henry M. Jackson Foundation for the Advancement of Military Medicine from 2009 to 2014. He also served as a Senior Scientist at the National Cancer Institute from 1995 to 1999, gaining extensive experience in the field of computational drug design.